Julian Gingold
Overview
Explore the profile of Julian Gingold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jain M, Blanco-Briendel M, Wu H, Gingold J, Lieman H
Fertil Steril
. 2024 Aug;
123(1):115-120.
PMID: 39098540
Objective: To determine whether industry payments to physicians are associated with a difference in assisted reproductive technology practices and outcomes. Design: Retrospective cohort. Patient(s): Patients undergoing asissted reproduction. Intervention(s): Industry...
2.
Massad N, Gingold J, Obanor O, Lerner V
J Gynecol Obstet Hum Reprod
. 2024 Feb;
53(5):102753.
PMID: 38395411
Background: Surgeons use electrosurgery daily, though most of them are unfamiliar with its basic safety principles. Method: We have designed a hands-on simulation session to teach OBGYN trainees principles of...
3.
Gerber R, Kappy M, Gingold J, Wu H, Lieman H, Singh M, et al.
Obstet Gynecol
. 2023 Nov;
143(1):92-100.
PMID: 37944144
Objective: To compare obstetric and neonatal outcomes after single embryo transfer (SET) compared with multiple embryo transfer (MET) from frozen-thawed transfer cycles of embryos that underwent preimplantation genetic testing for...
4.
Kappy M, Plagianos M, Gingold J, Jindal S, Klugman S, Lieman H
Fertil Steril
. 2023 Jul;
120(4):911-913.
PMID: 37459962
No abstract available.
5.
Sevilla A, Papatsenko D, Mazloom A, Xu H, Vasileva A, Unwin R, et al.
Front Cell Dev Biol
. 2021 Apr;
9:630067.
PMID: 33816475
Cell fate decisions during development are governed by multi-factorial regulatory mechanisms including chromatin remodeling, DNA methylation, binding of transcription factors to specific loci, RNA transcription and protein synthesis. However, the...
6.
Zhou R, Xu A, Wang D, Zhu D, Mata H, Huo Z, et al.
Stem Cell Res
. 2018 Feb;
27:131-135.
PMID: 29414603
The tumor suppressor gene TP53 is the most frequently mutated gene in human cancers. Many hot-spot mutations of TP53 confer novel functions not found in wild-type p53 and contribute to...
7.
Tu J, Huo Z, Liu M, Wang D, Xu A, Zhou R, et al.
Stem Cell Res
. 2018 Feb;
28:29-32.
PMID: 29414415
The Retinoblastoma 1 (RB1) tumor suppressor, a member of the Retinoblastoma gene family, functions as a pocket protein for the functional binding of E2F transcription factors. About 1/3 of retinoblastoma...
8.
Zhou R, Xu A, Gingold J, Strong L, Zhao R, Lee D
Trends Pharmacol Sci
. 2017 Aug;
38(10):908-927.
PMID: 28818333
Li-Fraumeni syndrome (LFS) is a rare hereditary autosomal dominant cancer disorder. Germline mutations in TP53, the gene encoding p53, are responsible for most cases of LFS. TP53 is also the...
9.
Lin Y, Jewell B, Gingold J, Lu L, Zhao R, Wang L, et al.
Trends Mol Med
. 2017 Jul;
23(8):737-755.
PMID: 28735817
Rare hereditary disorders provide unequivocal evidence of the importance of genes in human disease pathogenesis. Familial syndromes that predispose to osteosarcomagenesis are invaluable in understanding the underlying genetics of this...
10.
Tu J, Huo Z, Gingold J, Zhao R, Shen J, Lee D
Cancer Rep Rev
. 2017 Jun;
1(2).
PMID: 28626837
No abstract available.